Why MLAB beats the market
Up 80% in a year while the S&P 500 rose 7%.
“In fiscal year 2026, revenues grew 3.4% compared to fiscal 2025, driven primarily by growth in our Sterilization and Disinfection Control division”
MLAB's Quality Score fell 2 points on Fri, Nov 20, to 10. Its price fell under its average of 8 days (3 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 80% in a year while the S&P 500 rose 7%.
“In fiscal year 2026, revenues grew 3.4% compared to fiscal 2025, driven primarily by growth in our Sterilization and Disinfection Control division”
| Since its Dec 2021 high | Down 60% |
| Latest filing | 8-K, Nov 9 |
Tue Dec 1: Piper Sandler 38th Annual…Investor conference · date confirmed.
1 more date ahead: dividend dates, for Pro members.
After its last 4 reports it closed +2.7% on average, higher 3 of 4 times.
Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
MLAB is #3 of 11 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score |
Expected to report Wed Feb 3, after the close (in 74 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $62.3M, 3% more than a year ago; a profit of $0.75 a share, from $0.45.
“Growth was driven by SDC and CS, partially offset by BPD, which continued to be impacted by export-control processing delays, and CG.”
| Line | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Consumables | $35.8M | – | $33.4M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 9)
| Measure | Figure |
|---|---|
| Revenues | $250,000 to $255,000 |
Sales grew 13% a year over 5 years, fiscal 2021 to 2026.
Pays $0.64 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 9, 2026 | +1.2% | +7.1% | +4.9% |
| Aug 10, 2026 | -3.4% | +9.5% | +5.9% |
| May 27, 2026 | -0.9% | -14.5% | +0.5% |
Sales grew in six of the last seven years, to $249M in 2026. It turned a profit in 2026 after a loss in 2025.
RSI 46.7, MACD below signal, below its 50-day, above its 200-day. Not scored.
One insider bought $102K across 1 filing, and 3 insiders sold $518K across 3 filings, in the last 6 months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: MLAB is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
MLAB scores 10 today, which Breakaway calls Average. It is #3 of 11 in Industrial Instruments for Measurement, Display, and Control by Quality Score, with 3 of 14 chart checks firing. Up 80% in a year while the S&P 500 rose 7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
MLAB scores 10 today, which Breakaway calls Average (6 to 10). That is #3 of 11 in Industrial Instruments for Measurement, Display, and Control by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MLAB's 10.
One insider bought $102K across 1 filing, and 3 insiders sold $518K across 3 filings, in the last 6 months. The newest is R. Tony Tripeny, Director, who bought $102K on Aug 13. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.